Changes in visual acuity and macular edema were secondary outcomes in our study, showing only a mild trend toward improvement that did not reach statistical significance.
← all excerpts
Evaluating the Effectiveness of Escalating to Weekly Adalimumab Dosing for the Treatment of Noninfectious Uveitis: A Multicenter Study.
1
—
—